Chang Robotics, LLC, a leader in autonomous and robotic systems, and OTTO by Rockwell Automation, the autonomous mobile robot (AMR) division of Rockwell Automation, today announced they are teaming up ...

If 2025 taught us anything, it’s that the future of manufacturing is not just innovative; it’s safe, data-driven and ...

Kinemetrix's expansion is anticipated to support automated manufacturing and the region's growing electric vehicle industries.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

Cellares to provide proof-of-concept manufacturing for a key BMS CAR-T cell therapy Cellares' proprietary Cell Shuttle is a cost-efficient, reliable, fully automated, and highly scalable manufacturing ...

Power Technology has officially launched the world's first automated, high-volume production line in Conklin, New York, to ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

The manufacturing sector has matured significantly beyond the solo assembly lines of the past. The transition to smart ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

Lyell Immunopharma will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle™, through Cellares’ Technology Adoption Partnership (TAP) program. As part of the collaboration, the ...

Participants explore the various vendor booths at the Manufacturers Resource Center’s Automation & Manufacturing Technology Show Thursday, April, 25, 2024, at the Delta Hotel by Marriott, in Macungie.

Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...